Diagnostic biomarker of asbestos-related mesothelioma: example of translational research
- PMID: 17532755
- PMCID: PMC11159377
- DOI: 10.1111/j.1349-7006.2007.00520.x
Diagnostic biomarker of asbestos-related mesothelioma: example of translational research
Abstract
Mesothelioma is an aggressive tumor arising from the mesothelium, and is usually associated with previous exposure to asbestos. The incubation period of asbestos-related mesothelioma is estimated to be approximately 30-40 years. Once mesothelioma has occurred, there is no effective treatment. So, identification of tumor markers and a method for early diagnosis using such markers are urgently needed. Recently, several enzyme-linked immunosorbent assay systems for Erc/mesothelin have been developed, the reported usefulness of which has been assessed and demonstrated as a diagnostic tool. Asbestos-related mesothelioma should be ascribed as a typical environmental carcinogen. In this review, we will present asbestos-related mesothelioma for the study of problems in environmental carcinogenesis.
Figures
References
-
- Knudson AG. Hereditary cancer, oncogenes and antioncogenes. Cancer Res 1985; 45: 1437–43. - PubMed
-
- Hino O, Majima S, Kobayashi T et al . Multistep renal carcinogenesis as gene expression disease in tumor suppressor TSC2 gene mutant model – genotype, phenotype and environment. Mutat Res 2001; 477: 155–64. - PubMed
-
- Eker R, Mossige JA. A dominant gene for renal adenomas in the rat. Nature 1961; 189: 858–9.
-
- Kouchi M, Okimoto K, Matsumoto I, Tanaka K, Yasuba M, Hino O. Natural history of the Nihon (Bhd gene mutant) rat, a novel model for human Birt‐Hogg‐Dube syndrome. Virchows Arch 2006; 448: 463–71. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
